Related Experiment Video
Updated: May 22, 2026

Drug-Induced Senescence in Liver Cells Promotes M2 Macrophage Polarization: Implications for Tyrosine Kinase Inhibitor-Associated Hepatotoxicity
Published on: October 17, 2025
β-Lapachone analogs with enhanced antiproliferative activity
Carla Ríos-Luci1, Evelyn L Bonifazi, Leticia G León
1BioLab, Instituto Universitario de Bio-Orgánica Antonio González, Universidad de La Laguna, 38206 La Laguna, Spain.
Researchers synthesized novel lapachone analogs, identifying 7-hydroxy-β-lapachone as a potent antiproliferative agent against solid tumors. Its efficacy stems from reactive oxygen species (ROS) generation and DNA damage, similar to β-lapachone.
Area of Science:
- Medicinal Chemistry
- Organic Synthesis
- Cancer Biology
Background:
- Lapachone derivatives are investigated for their antiproliferative properties.
- Understanding structure-activity relationships is crucial for developing new cancer therapeutics.
Purpose of the Study:
- To synthesize novel α- and β-lapachone analogs with hydroxyl or methoxyl substitutions.
- To evaluate the antiproliferative activity of these compounds against human solid tumor cell lines.
- To elucidate the mechanism of action for the most potent analog.
Main Methods:
- Selective acid-promoted cyclization of lapachol analogs.
- Antiproliferative assays using human solid tumor cell lines.
- Cell cycle analysis, protein expression studies, and reactive oxygen species (ROS) detection.
Main Results:
- A series of α- and β-lapachone derivatives were successfully synthesized.
- 7-hydroxy-β-lapachone demonstrated enhanced antiproliferative activity compared to β-lapachone.
- 7-hydroxy-β-lapachone induces cellular toxicity through ROS formation and DNA damage.
Conclusions:
- 7-hydroxy-β-lapachone is a promising lead compound for solid tumor treatment.
- The mechanism of action involves ROS generation and DNA damage, similar to β-lapachone.
- Further investigation into lapachone analogs could yield novel anticancer agents.
Related Concept Videos
Adrenergic Antagonists: ɑ and β-Receptor Blockers
Bioavailability Enhancement: Drug Permeability Enhancement
The Intrinsic Apoptotic Pathway
